儿童心脏肌钙蛋白检测与应用的当前及未来指征
本综述由国际临床化学与检验医学联合会心脏生物标志物临床应用委员会成员与儿科、心内科、急诊科医生及检验人员共同讨论并评估现有文献,总结儿童心脏肌钙蛋白(cTn)检测的当前知识与最佳实践,涉及参考上限百分位选择、年龄性别生理影响、分析前与分析注意事项及结果解读共识。健康婴儿和新生儿cTn浓度高,1-3岁达最低点后逐渐升高至青春期达成人水平;心肌损伤发生率低且取决于选择97.5th还是99th百分位为上限;主要临床检测指征为疑似心肌/心包炎或胸部创伤。
要点
- 健康婴儿和新生儿cTn浓度高,1-3岁达最低点后逐渐升高至青春期达成人水平。
- 儿童心肌损伤发生率低,且取决于以97.5th还是99th百分位作为参考上限。
- 主要检测指征为疑似心肌/心包炎或胸部创伤,偶用于可能的心力衰竭和/或心肌缺血。
核心结论
- 儿童cTn检测的临床使用和解读存在异质性,当前实践建议主要基于专家意见。
- 健康婴儿和新生儿cTn浓度高,1-3岁达最低点后逐渐升高至青春期达成人水平。
- 儿童心肌损伤发生率低,且取决于选择97.5th还是99th百分位作为上限参考限。
研究设计与样本
- 本综述基于对现有文献的评估与综合,以及国际临床化学与检验医学联合会心脏生物标志物临床应用委员会成员与儿科医生、心内科医生、急诊科医生及检验人员之间的讨论。
主要发现
- 当前研究报告健康婴儿和新生儿cTn浓度高,1-3岁达最低点后逐渐升高,青春期达成人水平。
- 儿童心肌损伤发生率低,且取决于选择97.5th还是99th百分位作为上限参考限。
- 主要临床检测指征为疑似心肌/心包炎或胸部创伤,偶用于可能的心力衰竭和/或心肌缺血。
- 已发表的有限临床研究存在异质性,多数数据为回顾性。
关键数值与推荐
- 应选择哪个百分位作为儿童cTn上限参考限尚待明确,且影响心肌损伤发生率。
- 年龄、性别和生理状态影响循环cTn浓度。
- 需考虑分析前和分析注意事项,并就报告结果的最佳解读达成共识。
临床怎么用
- 临床检测cTn主要用于疑似心肌/心包炎或胸部创伤的儿童。
- 解读儿童cTn结果时需考虑年龄相关的浓度变化,婴儿和新生儿浓度较高。
- 选择97.5th或99th百分位作为上限参考限会影响心肌损伤的判定。
局限性
- 已发表的有限临床研究存在异质性,多数数据为回顾性。
- 当前临床实践建议主要基于专家意见。
- 需要更多关于儿童cTn检测各方面的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical use and interpretation of cardiac troponins (cTn) in pediatric patients is heterogeneous. CONTENT: This review is based on an appraisal and synthesis of the available literature and discussions between International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Application of Cardiac Biomarkers members and pediatricians, cardiologists, emergency department physicians, and laboratorians. It aims to summarize current knowledge and best practices related to cTn measurements in pediatric patients, including which percentile should be applicable as the upper reference limit, and the influence of age, sex, and physiology on circulating concentrations. Preanalytical and analytical precautions, and a consensus on optimal interpretation of the reported results are discussed. SUMMARY: Current studies report high cTn concentrations in healthy infants and newborns. The nadir is reached at 1-3 years at which time concentrations gradually increase, reaching adult levels through puberty. The incidence of myocardial injury is reported to be low and dependent on whether the 97.5th or 99th percentile is chosen as the upper reference limit. The main clinical indication for testing appears to be suspicion of myo/pericarditis or traumatic chest injury. On occasion, cTn is measured in cases of possible heart failure and/or myocardial ischemia. There is heterogeneity among the limited clinical studies published. Most of the data are retrospective, and the current suggestions for clinical practice are thus largely based on expert opinion. More research is needed regarding all aspects of cTn testing in children, and suggestions for future research are included at the end of this review.
引用
- Aakre KM, Jeewa A, Cullen L, et al. Current and Future Indication for Testing and Use of Cardiac Troponin in Children. Clin Chem. 2026. PMID: 41894471. doi:10.1093/clinchem/hvag021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。